Fortem Financial Group, LLC Teva Pharmaceutical Industries LTD Transaction History

Fortem Financial Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$7.9 - $10.19 $138,250 - $178,325	-17,500 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$8.38 - $10.18 $16,760 - $20,360	2,000 Added 12.9%	17,500 $170,000
Q2 2021 Jul 14, 2021	SELL	$9.9 - $11.56 $99,000 - $115,600	-10,000 Reduced 39.22%	15,500 $153,000
Q1 2021 Apr 20, 2021	SELL	$10.34 - $12.81 $25,850 - $32,025	-2,500 Reduced 8.93%	25,500 $294,000
Q4 2020 Jan 29, 2021	SELL	$8.61 - $11.04 $8,610 - $11,040	-1,000 Reduced 3.45%	28,000 $270,000
Q3 2020 Oct 15, 2020	BUY	$8.57 - $12.69 $21,425 - $31,725	2,500 Added 9.43%	29,000 $261,000
Q1 2020 Apr 23, 2020	BUY	$6.69 - $13.45 $26,760 - $53,800	4,000 Added 17.78%	26,500 $238,000
Q4 2019 Feb 11, 2020	BUY	$6.53 - $10.72 $3,265 - $5,360	500 Added 2.27%	22,500 $221,000
Q3 2019 Nov 12, 2019	SELL	$6.16 - $9.6 $136,752 - $213,120	-22,200 Reduced 50.23%	22,000 $151,000
Q2 2019 Aug 09, 2019	BUY	$8.12 - $15.72 $358,903 - $694,824	44,200 New	44,200 $408,000
Q1 2019 May 13, 2019	SELL	$15.58 - $20.01 $247,722 - $318,159	-15,900 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $231,981 - $379,056	15,900 New	15,900 $245,000

624

565M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortem Financial Group, LLC with notifications on news.